Aytu BioPharma, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic · United States

Last price 1.93 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 20.97M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT extended-release orally disintegrating tablets for patients from six years of age and above; Cotempla XR-ODT A central nervous system stimulant indicated for the treatment of ADHD in patients 6 to 17 years of age; and Metadate CD, a central nervous system stimulant indicated fo...